Sign Up
B 23-0430 District of Columbia · 23rd Council Period (2019-2020)

Access to Biosimilars Amendment Act of 2019

Bill status signed all 4 stages cleared
Introduction
Sep 2019
Committee Review
Jul 2020
Council Passage
Jul 2020
Signed into Law
Nov 2020
Introduced Sep 17, 2019 Signed Nov 13, 2020
Floor votes · Council Jul 21, 2020

How they voted

13–0
Passed
Total votes 13
Jul 21, 2020
D Democratic10
10 Yea
100% Yea
I Independent3
3 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
17
Key actions
3
Committee
3
Nov 13, 2020
Became law
Law L23-0133, Effective from Oct 20, 2020 Published in DC Register Vol 67 and Page 13198
Aug 13, 2020
Signed into law
Signed by the Mayor and Enacted with Act Number A23-0387
Jul 21, 2020
Council · Passed
Council Vote: pass (13-0)
Jul 1, 2020
Legislature · Reported by committee
Committee Report Filed, Includes Hearing Record
Jul 1, 2020
Legislature · Reported by committee
Committee Mark-up of B23-0430
Sep 17, 2019
Legislature · Referred to committee
Referred to Committee on Health
Sep 17, 2019
Legislature · Introduced
B23-0430 Introduced by Councilmembers Cheh, Todd, Bonds, Allen, Nadeau, Silverman, Gray, and Evans at Committee of the Whole
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.